Select Medical Holdings Corporation (SEM) 10-Year Financial Performance & Capital Metrics

SEM •

HealthcareHealthcare FacilitiesPost-acute and senior care

AboutSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.Show more

Revenue $5.45B +5.1%
EBITDA $142M -70.0%
Net Income $146M -31.7%
EPS (Diluted) 1.16 -30.1%
Gross Margin 11.54% -5.5%
EBITDA Margin 2.6% -71.4%
Operating Margin 0.03% -99.4%
Net Margin 2.68% -35.0%
ROE 7.25% -39.5%
ROIC 0.03% -99.2%
Debt/Equity 0.51 -62.0%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 100.0% through buybacks
✓Trading at only 0.9x book value

✗Weaknesses

✗Profits declining 10.8% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y3.83%

5Y-0.29%

3Y-4.87%

TTM-34.98%

Profit (Net Income) CAGR

10Y1.13%

5Y-10.8%

3Y-2.75%

TTM-60.2%

EPS CAGR

10Y1.6%

5Y-9.68%

3Y-1.93%

TTM-59.35%

ROCE

10Y Avg7.25%

5Y Avg6.29%

3Y Avg4.48%

Latest0.03%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	4.29B	4.44B	5.08B	5.45B	5.53B	6.2B	6.33B	6.66B	5.19B	5.45B
Revenue Growth %	14.52%	3.68%	14.35%	7.33%	1.43%	12.16%	2.08%	5.22%	-22.16%	5.12%
Cost of Goods Sold+	3.66B	3.73B	4.34B	4.64B	4.71B	5.29B	5.6B	5.73B	4.55B	4.82B
COGS % of Revenue	85.51%	84.03%	85.43%	85.09%	85.15%	85.18%	88.42%	86.01%	87.78%	88.46%
Gross Profit+	621.18M	709.43M	740.2M	812.92M	821.34M	919.37M	733.38M	932.04M	633.64M	629.29M
Gross Margin %	14.49%	15.97%	14.57%	14.91%	14.85%	14.82%	11.58%	13.99%	12.22%	11.54%
Gross Profit Growth %	16.94%	14.21%	4.34%	9.82%	1.04%	11.93%	-20.23%	27.09%	-32.02%	-0.69%
Operating Expenses+	252.24M	274.06M	322.92M	341.04M	253.68M	205.59M	330.09M	377.17M	365.33M	294.72M
OpEx % of Revenue	5.89%	6.17%	6.36%	6.25%	4.59%	3.31%	5.21%	5.66%	7.04%	5.4%
Selling, General & Admin	106.93M	114.05M	121.27M	128.46M	138.04M	146.97M	153.03M	170.19M	225.87M	154.41M
SG&A % of Revenue	2.49%	2.57%	2.39%	2.36%	2.5%	2.37%	2.42%	2.55%	4.35%	2.83%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	42.65M	-49K	201.66M	212.58M	115.65M	58.62M	177.06M	206.97M	139.46M	140.3M
Operating Income+	299.85M	355.88M	417.28M	471.88M	567.66M	713.77M	403.28M	554.87M	268.31M	1.59M
Operating Margin %	7%	8.01%	8.21%	8.65%	10.26%	11.5%	6.37%	8.33%	5.17%	0.03%
Operating Income Growth %	9.12%	18.69%	17.25%	13.09%	20.3%	25.74%	-43.5%	37.59%	-51.64%	-99.41%
EBITDA+	445.16M	515.89M	618.93M	684.46M	773.32M	916.42M	609.11M	763.62M	472.21M	141.9M
EBITDA Margin %	10.39%	11.61%	12.18%	12.55%	13.98%	14.77%	9.62%	11.46%	9.1%	2.6%
EBITDA Growth %	17.22%	15.89%	19.97%	10.59%	12.98%	18.51%	-33.53%	25.37%	-38.16%	-69.95%
D&A (Non-Cash Add-back)	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M	140.3M
EBIT	303.08M	357.16M	420.17M	465.32M	477.64M	765.71M	429.69M	581M	303.37M	0
Net Interest Income+	-170.08M	-154.7M	-198.49M	-200.57M	-153.01M	-130.63M	-169.11M	-198.64M	-128.6M	0
Interest Income	0	0	0	0	0	5.35M	0	0	0	0
Interest Expense	170.08M	154.7M	198.49M	200.57M	153.01M	135.99M	169.11M	198.64M	128.6M	-117.94M
Other Income/Expense	-119.11M	-153.42M	-181.73M	-207.13M	-111.18M	-84.05M	-142.7M	-172.52M	-93.55M	271.16M
Pretax Income+	180.73M	202.46M	235.55M	264.75M	456.47M	629.72M	260.58M	382.36M	174.77M	272.75M
Pretax Margin %	4.22%	4.56%	4.64%	4.85%	8.25%	10.15%	4.11%	5.74%	3.37%	5%
Income Tax+	55.46M	-18.18M	58.61M	63.72M	111.87M	129.77M	62.55M	82.63M	44.78M	58.22M
Effective Tax Rate %	63.86%	87.52%	58.52%	56.07%	56.74%	63.87%	61.02%	63.68%	122.47%	53.61%
Net Income+	115.41M	177.18M	137.84M	148.45M	259M	402.23M	158.99M	243.49M	214.04M	146.22M
Net Margin %	2.69%	3.99%	2.71%	2.72%	4.68%	6.48%	2.51%	3.65%	4.13%	2.68%
Net Income Growth %	-11.72%	53.52%	-22.21%	7.7%	74.47%	55.3%	-60.47%	53.14%	-12.1%	-31.69%
Net Income (Continuing)	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	129.99M	146.22M
Discontinued Operations	0	0	0	0	0	0	0	0	166.72M	0
Minority Interest	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M	18.81M
EPS (Diluted)+	0.87	0.87	1.06	1.54	1.93	2.99	1.23	1.91	1.66	1.16
EPS Growth %	-12.12%	0%	21.84%	45.28%	25.32%	54.92%	-58.86%	55.28%	-13.09%	-30.12%
EPS (Basic)	0.88	1.33	1.06	1.54	1.93	2.99	1.23	1.91	1.66	1.16
Diluted Shares Outstanding	127.97M	129.13M	130.26M	130.28M	129.78M	130.25M	124.63M	123.11M	124.61M	0
Basic Shares Outstanding	127.81M	128.96M	130.17M	130.25M	129.78M	130.25M	124.63M	123.11M	129.19M	0
Dividend Payout Ratio	-	-	-	-	-	12.58%	40.62%	26.24%	30.19%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	808.07M	920.83M	992.52M	1.21B	1.59B	1.14B	1.27B	1.26B	1.02B	1.03B
Cash & Short-Term Investments	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	172.76M	111.59M	59.69M	26.52M
Cash Only	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	97.91M	52.63M	59.69M	26.52M
Short-Term Investments	0	0	0	0	0	0	74.86M	58.96M	0	0
Accounts Receivable	573.75M	691.73M	706.68M	768.38M	896.76M	889.3M	941.31M	724.14M	821.38M	864.21M
Days Sales Outstanding	48.86	56.82	50.76	51.42	59.17	52.32	54.25	39.66	57.8	57.85
Inventory	-627.62M	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	90.12M	106.55M	110.67M	90.15M	114.49M	120.21M	125.37M	407.16M	138.7M	134.55M
Total Non-Current Assets+	4.14B	4.21B	4.97B	6.13B	6.06B	6.22B	6.39B	6.43B	4.59B	4.83B
Property, Plant & Equipment	892.22M	912.59M	979.81M	2B	1.98B	2.04B	2.17B	1.64B	1.78B	1.95B
Fixed Asset Turnover	4.80x	4.87x	5.19x	2.72x	2.80x	3.04x	2.92x	4.07x	2.91x	2.80x
Goodwill	2.75B	2.78B	3.32B	3.39B	3.38B	3.45B	3.48B	2.28B	2.33B	2.36B
Intangible Assets	340.56M	326.52M	437.69M	409.07M	387.54M	374.88M	351.66M	105.15M	103.18M	100.8M
Long-Term Investments	-4.03B	114.2M	146.9M	28.7M	2.5M	18.05M	45.2M	0	320.9M	0
Other Non-Current Assets	4.14B	184.42M	233.51M	295.18M	316.71M	338.67M	341.74M	2.41B	51.91M	414.39M
Total Assets+	4.94B	5.13B	5.96B	7.34B	7.66B	7.36B	7.67B	7.69B	5.61B	5.85B
Asset Turnover	0.87x	0.87x	0.85x	0.74x	0.72x	0.84x	0.83x	0.87x	0.92x	0.93x
Asset Growth %	11.7%	3.7%	16.33%	23.07%	4.29%	-3.86%	4.15%	0.32%	-27.07%	4.34%
Total Current Liabilities+	571.63M	605.4M	705.19M	914.28M	1.44B	1.27B	1.16B	1.25B	977.65M	984.49M
Accounts Payable	126.56M	128.19M	146.69M	145.73M	177.09M	233.84M	186.73M	153.9M	142.16M	157.06M
Days Payables Outstanding	12.6	12.53	12.33	11.46	13.72	16.15	12.17	9.8	11.4	11.89
Short-Term Debt	53.02M	51.65M	68.95M	233.12M	233.03M	59.92M	76.31M	99.15M	46.07M	212.62M
Deferred Revenue (Current)	378.4M	29.46M	25.08M	0	0	83.79M	0	0	0	0
Other Current Liabilities	0	255.93M	313.49M	224.93M	662.6M	0	0	271.28M	0	771.87M
Current Ratio	1.41x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x	1.04x
Quick Ratio	2.51x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x	1.04x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.47B	3.59B	4.34B	4.52B	4.57B	4.72B	5.12B	4.87B	2.63B	2.83B
Long-Term Debt	2.69B	2.68B	3.25B	3.42B	3.39B	3.56B	3.84B	3.58B	1.69B	835.36M
Capital Lease Obligations	0	0	0	852.9M	875.37M	916.54M	1.01B	668.56M	797.14M	0
Deferred Tax Liabilities	222.85M	124.92M	153.9M	148.26M	132.42M	142.79M	169.79M	119.94M	81.5M	112.16M
Other Non-Current Liabilities	558.68M	145.71M	158.94M	101.33M	168.7M	106.44M	106.14M	494.27M	73.04M	1.88B
Total Liabilities	4.04B	4.19B	5.05B	5.44B	6B	6B	6.27B	6.12B	3.61B	3.82B
Total Debt+	2.74B	2.7B	3.29B	4.51B	4.5B	4.76B	5.16B	4.52B	2.7B	1.05B
Net Debt	2.64B	2.58B	3.12B	4.17B	3.92B	4.69B	5.06B	4.47B	2.64B	1.02B
Debt / Equity	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x	0.51x
Debt / EBITDA	6.15x	5.23x	5.32x	6.58x	5.82x	5.20x	8.47x	5.93x	5.73x	7.39x
Net Debt / EBITDA	5.93x	5.00x	5.04x	6.09x	5.07x	5.12x	8.31x	5.86x	5.60x	7.20x
Interest Coverage	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x	-
Total Equity+	996.08M	1.04B	1.03B	1.9B	1.65B	1.36B	1.39B	1.57B	2B	2.04B
Equity Growth %	4%	4.59%	-1.19%	84.91%	-13.26%	-17.33%	1.88%	13.19%	26.88%	1.93%
Book Value per Share	7.78	8.07	7.90	14.61	12.72	10.48	11.16	12.79	16.03	16.41
Total Shareholders' Equity	905.9M	932.6M	916.24M	770.97M	1.06B	1.11B	1.12B	1.29B	1.68B	1.71B
Common Stock	132K	134K	135K	134K	135K	134K	127K	128K	129K	124K
Retained Earnings	371.69M	359.74M	320.35M	279.8M	553.24M	593.25M	581.01M	751.86M	770.15M	837.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-512.75M	-630.66M	-764.58M	0	-2.03M	12.28M	88.6M	42.91M	0	-6.4M
Minority Interest	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M	18.81M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	346.6M	238.13M	494.19M	445.18M	1.03B	401.23M	284.82M	582.06M	517.86M	346.47M
Operating CF Margin %	8.09%	5.36%	9.73%	8.16%	18.59%	6.47%	4.5%	8.73%	9.98%	6.35%
Operating CF Growth %	66.3%	-31.3%	107.53%	-9.92%	130.93%	-60.97%	-29.01%	104.36%	-11.03%	-33.1%
Net Income	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	296.7M	146.22M
Depreciation & Amortization	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M	140.3M
Stock-Based Compensation	17.41M	19.28M	23.33M	26.45M	27.25M	30.94M	37.76M	43.81M	100.67M	16.7M
Deferred Taxes	-12.59M	-72.32M	7.22M	-7.43M	-14.71M	5.05M	7.52M	-16.12M	-32.43M	30.65M
Other Non-Cash Items	52.98M	85.75M	656K	25.65M	-13.82M	-7.38M	-4.76M	-13.6M	4.17M	12.59M
Working Capital Changes	18.22M	-175.24M	84.4M	-13.09M	479.1M	-329.98M	-159.54M	59.5M	-55.14M	0
Change in Receivables	-39.32M	-197.19M	54.58M	-57.99M	-116.6M	23.1M	-52.18M	1.16M	-95.84M	-45.19M
Change in Inventory	17.45M	1.6M	0	0	167.65M	-82.77M	0	0	0	0
Change in Payables	30.8M	21.24M	26.12M	5.74M	27.32M	53.39M	-48.04M	-6.41M	-16.79M	-854K
Cash from Investing+	-554.32M	-192.97M	-697.14M	-316.73M	-115.35M	-256.59M	-226.34M	-268.48M	-231.01M	-216.49M
Capital Expenditures	-161.63M	-233.24M	-167.28M	-157.13M	-146.44M	-180.54M	-190.37M	-229.2M	-222.18M	36.27M
CapEx % of Revenue	3.77%	5.25%	3.29%	2.88%	2.65%	2.91%	3.01%	3.44%	4.28%	0.67%
Acquisitions	-473.15M	-40.07M	-536.62M	-159.79M	-52.23M	-102.88M	-44.31M	-39.44M	-13.1M	-9.2M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	80.46M	80.35M	6.76M	192K	83.32M	26.82M	8.34M	163K	4.26M	-243.56M
Cash from Financing+	292.31M	-21.65M	255.57M	32.25M	-671.54M	-647.38M	-34.89M	-327.48M	-311.17M	-163.15M
Debt Issued (Net)	294.38M	-18.27M	570.92M	73.46M	-48.12M	195.7M	264.68M	-203.95M	-493.46M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	1000K	0
Dividends Paid	0	0	0	0	0	-50.6M	-64.59M	-63.9M	-64.62M	-31.43M
Share Repurchases	-2.93M	-4.75M	-6.84M	-38.53M	-16.03M	-79.48M	-195.53M	-12.76M	-37.91M	-100.08M
Other Financing	864K	1.38M	-308.51M	-2.68M	-607.39M	-713.01M	-39.45M	-46.86M	-226.38M	-131.72M
Net Change in Cash	84.59M	23.52M	52.63M	160.7M	241.18M	-502.75M	23.6M	-13.9M	-24.31M	-33.17M
Free Cash Flow+	184.97M	4.89M	326.91M	288.06M	881.63M	220.69M	94.45M	352.86M	539.65M	382.74M
FCF Margin %	4.32%	0.11%	6.43%	5.28%	15.94%	3.56%	1.49%	5.29%	10.4%	7.02%
FCF Growth %	617.69%	-97.36%	6588.07%	-11.89%	206.06%	-74.97%	-57.2%	273.58%	52.94%	-29.08%
FCF per Share	1.45	0.04	2.51	2.21	6.79	1.69	0.76	2.87	4.33	3.09
FCF Conversion (FCF/Net Income)	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x	2.37x
Interest Paid	142.64M	149.16M	193.41M	182.99M	155.24M	132.2M	183.45M	272.26M	256.23M	0
Taxes Paid	70.76M	64.99M	48.15M	70.59M	108.89M	181.18M	32.29M	88.51M	133.19M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	11.81%	17.39%	13.31%	10.12%	14.57%	26.67%	11.54%	16.43%	11.99%	7.25%
Return on Invested Capital (ROIC)	6.4%	7.36%	8.06%	6.93%	7.31%	9.21%	4.84%	6.66%	3.77%	0.03%
Gross Margin	14.49%	15.97%	14.57%	14.91%	14.85%	14.82%	11.58%	13.99%	12.22%	11.54%
Net Margin	2.69%	3.99%	2.71%	2.72%	4.68%	6.48%	2.51%	3.65%	4.13%	2.68%
Debt / Equity	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x	0.51x
Interest Coverage	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x	-
FCF Conversion	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x	2.37x
Revenue Growth	14.52%	3.68%	14.35%	7.33%	1.43%	12.16%	2.08%	5.22%	-22.16%	5.12%

US Stock Screener

...

Select Medical Holdings Corporation (SEM) 10-Year Financial Performance & Capital Metrics

SEM •

HealthcareHealthcare FacilitiesPost-acute and senior care

Revenue $5.45B +5.1%
EBITDA $142M -70.0%
Net Income $146M -31.7%
EPS (Diluted) 1.16 -30.1%
Gross Margin 11.54% -5.5%
EBITDA Margin 2.6% -71.4%
Operating Margin 0.03% -99.4%
Net Margin 2.68% -35.0%
ROE 7.25% -39.5%
ROIC 0.03% -99.2%
Debt/Equity 0.51 -62.0%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 100.0% through buybacks
✓Trading at only 0.9x book value

✗Weaknesses

✗Profits declining 10.8% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y3.83%

5Y-0.29%

3Y-4.87%

TTM-34.98%

Profit (Net Income) CAGR

10Y1.13%

5Y-10.8%

3Y-2.75%

TTM-60.2%

EPS CAGR

10Y1.6%

5Y-9.68%

3Y-1.93%

TTM-59.35%

ROCE

10Y Avg7.25%

5Y Avg6.29%

3Y Avg4.48%

Latest0.03%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	4.29B	4.44B	5.08B	5.45B	5.53B	6.2B	6.33B	6.66B	5.19B	5.45B
Revenue Growth %	14.52%	3.68%	14.35%	7.33%	1.43%	12.16%	2.08%	5.22%	-22.16%	5.12%
Cost of Goods Sold+	3.66B	3.73B	4.34B	4.64B	4.71B	5.29B	5.6B	5.73B	4.55B	4.82B
COGS % of Revenue	85.51%	84.03%	85.43%	85.09%	85.15%	85.18%	88.42%	86.01%	87.78%	88.46%
Gross Profit+	621.18M	709.43M	740.2M	812.92M	821.34M	919.37M	733.38M	932.04M	633.64M	629.29M
Gross Margin %	14.49%	15.97%	14.57%	14.91%	14.85%	14.82%	11.58%	13.99%	12.22%	11.54%
Gross Profit Growth %	16.94%	14.21%	4.34%	9.82%	1.04%	11.93%	-20.23%	27.09%	-32.02%	-0.69%
Operating Expenses+	252.24M	274.06M	322.92M	341.04M	253.68M	205.59M	330.09M	377.17M	365.33M	294.72M
OpEx % of Revenue	5.89%	6.17%	6.36%	6.25%	4.59%	3.31%	5.21%	5.66%	7.04%	5.4%
Selling, General & Admin	106.93M	114.05M	121.27M	128.46M	138.04M	146.97M	153.03M	170.19M	225.87M	154.41M
SG&A % of Revenue	2.49%	2.57%	2.39%	2.36%	2.5%	2.37%	2.42%	2.55%	4.35%	2.83%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	42.65M	-49K	201.66M	212.58M	115.65M	58.62M	177.06M	206.97M	139.46M	140.3M
Operating Income+	299.85M	355.88M	417.28M	471.88M	567.66M	713.77M	403.28M	554.87M	268.31M	1.59M
Operating Margin %	7%	8.01%	8.21%	8.65%	10.26%	11.5%	6.37%	8.33%	5.17%	0.03%
Operating Income Growth %	9.12%	18.69%	17.25%	13.09%	20.3%	25.74%	-43.5%	37.59%	-51.64%	-99.41%
EBITDA+	445.16M	515.89M	618.93M	684.46M	773.32M	916.42M	609.11M	763.62M	472.21M	141.9M
EBITDA Margin %	10.39%	11.61%	12.18%	12.55%	13.98%	14.77%	9.62%	11.46%	9.1%	2.6%
EBITDA Growth %	17.22%	15.89%	19.97%	10.59%	12.98%	18.51%	-33.53%	25.37%	-38.16%	-69.95%
D&A (Non-Cash Add-back)	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M	140.3M
EBIT	303.08M	357.16M	420.17M	465.32M	477.64M	765.71M	429.69M	581M	303.37M	0
Net Interest Income+	-170.08M	-154.7M	-198.49M	-200.57M	-153.01M	-130.63M	-169.11M	-198.64M	-128.6M	0
Interest Income	0	0	0	0	0	5.35M	0	0	0	0
Interest Expense	170.08M	154.7M	198.49M	200.57M	153.01M	135.99M	169.11M	198.64M	128.6M	-117.94M
Other Income/Expense	-119.11M	-153.42M	-181.73M	-207.13M	-111.18M	-84.05M	-142.7M	-172.52M	-93.55M	271.16M
Pretax Income+	180.73M	202.46M	235.55M	264.75M	456.47M	629.72M	260.58M	382.36M	174.77M	272.75M
Pretax Margin %	4.22%	4.56%	4.64%	4.85%	8.25%	10.15%	4.11%	5.74%	3.37%	5%
Income Tax+	55.46M	-18.18M	58.61M	63.72M	111.87M	129.77M	62.55M	82.63M	44.78M	58.22M
Effective Tax Rate %	63.86%	87.52%	58.52%	56.07%	56.74%	63.87%	61.02%	63.68%	122.47%	53.61%
Net Income+	115.41M	177.18M	137.84M	148.45M	259M	402.23M	158.99M	243.49M	214.04M	146.22M
Net Margin %	2.69%	3.99%	2.71%	2.72%	4.68%	6.48%	2.51%	3.65%	4.13%	2.68%
Net Income Growth %	-11.72%	53.52%	-22.21%	7.7%	74.47%	55.3%	-60.47%	53.14%	-12.1%	-31.69%
Net Income (Continuing)	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	129.99M	146.22M
Discontinued Operations	0	0	0	0	0	0	0	0	166.72M	0
Minority Interest	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M	18.81M
EPS (Diluted)+	0.87	0.87	1.06	1.54	1.93	2.99	1.23	1.91	1.66	1.16
EPS Growth %	-12.12%	0%	21.84%	45.28%	25.32%	54.92%	-58.86%	55.28%	-13.09%	-30.12%
EPS (Basic)	0.88	1.33	1.06	1.54	1.93	2.99	1.23	1.91	1.66	1.16
Diluted Shares Outstanding	127.97M	129.13M	130.26M	130.28M	129.78M	130.25M	124.63M	123.11M	124.61M	0
Basic Shares Outstanding	127.81M	128.96M	130.17M	130.25M	129.78M	130.25M	124.63M	123.11M	129.19M	0
Dividend Payout Ratio	-	-	-	-	-	12.58%	40.62%	26.24%	30.19%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	808.07M	920.83M	992.52M	1.21B	1.59B	1.14B	1.27B	1.26B	1.02B	1.03B
Cash & Short-Term Investments	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	172.76M	111.59M	59.69M	26.52M
Cash Only	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	97.91M	52.63M	59.69M	26.52M
Short-Term Investments	0	0	0	0	0	0	74.86M	58.96M	0	0
Accounts Receivable	573.75M	691.73M	706.68M	768.38M	896.76M	889.3M	941.31M	724.14M	821.38M	864.21M
Days Sales Outstanding	48.86	56.82	50.76	51.42	59.17	52.32	54.25	39.66	57.8	57.85
Inventory	-627.62M	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	90.12M	106.55M	110.67M	90.15M	114.49M	120.21M	125.37M	407.16M	138.7M	134.55M
Total Non-Current Assets+	4.14B	4.21B	4.97B	6.13B	6.06B	6.22B	6.39B	6.43B	4.59B	4.83B
Property, Plant & Equipment	892.22M	912.59M	979.81M	2B	1.98B	2.04B	2.17B	1.64B	1.78B	1.95B
Fixed Asset Turnover	4.80x	4.87x	5.19x	2.72x	2.80x	3.04x	2.92x	4.07x	2.91x	2.80x
Goodwill	2.75B	2.78B	3.32B	3.39B	3.38B	3.45B	3.48B	2.28B	2.33B	2.36B
Intangible Assets	340.56M	326.52M	437.69M	409.07M	387.54M	374.88M	351.66M	105.15M	103.18M	100.8M
Long-Term Investments	-4.03B	114.2M	146.9M	28.7M	2.5M	18.05M	45.2M	0	320.9M	0
Other Non-Current Assets	4.14B	184.42M	233.51M	295.18M	316.71M	338.67M	341.74M	2.41B	51.91M	414.39M
Total Assets+	4.94B	5.13B	5.96B	7.34B	7.66B	7.36B	7.67B	7.69B	5.61B	5.85B
Asset Turnover	0.87x	0.87x	0.85x	0.74x	0.72x	0.84x	0.83x	0.87x	0.92x	0.93x
Asset Growth %	11.7%	3.7%	16.33%	23.07%	4.29%	-3.86%	4.15%	0.32%	-27.07%	4.34%
Total Current Liabilities+	571.63M	605.4M	705.19M	914.28M	1.44B	1.27B	1.16B	1.25B	977.65M	984.49M
Accounts Payable	126.56M	128.19M	146.69M	145.73M	177.09M	233.84M	186.73M	153.9M	142.16M	157.06M
Days Payables Outstanding	12.6	12.53	12.33	11.46	13.72	16.15	12.17	9.8	11.4	11.89
Short-Term Debt	53.02M	51.65M	68.95M	233.12M	233.03M	59.92M	76.31M	99.15M	46.07M	212.62M
Deferred Revenue (Current)	378.4M	29.46M	25.08M	0	0	83.79M	0	0	0	0
Other Current Liabilities	0	255.93M	313.49M	224.93M	662.6M	0	0	271.28M	0	771.87M
Current Ratio	1.41x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x	1.04x
Quick Ratio	2.51x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x	1.04x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.47B	3.59B	4.34B	4.52B	4.57B	4.72B	5.12B	4.87B	2.63B	2.83B
Long-Term Debt	2.69B	2.68B	3.25B	3.42B	3.39B	3.56B	3.84B	3.58B	1.69B	835.36M
Capital Lease Obligations	0	0	0	852.9M	875.37M	916.54M	1.01B	668.56M	797.14M	0
Deferred Tax Liabilities	222.85M	124.92M	153.9M	148.26M	132.42M	142.79M	169.79M	119.94M	81.5M	112.16M
Other Non-Current Liabilities	558.68M	145.71M	158.94M	101.33M	168.7M	106.44M	106.14M	494.27M	73.04M	1.88B
Total Liabilities	4.04B	4.19B	5.05B	5.44B	6B	6B	6.27B	6.12B	3.61B	3.82B
Total Debt+	2.74B	2.7B	3.29B	4.51B	4.5B	4.76B	5.16B	4.52B	2.7B	1.05B
Net Debt	2.64B	2.58B	3.12B	4.17B	3.92B	4.69B	5.06B	4.47B	2.64B	1.02B
Debt / Equity	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x	0.51x
Debt / EBITDA	6.15x	5.23x	5.32x	6.58x	5.82x	5.20x	8.47x	5.93x	5.73x	7.39x
Net Debt / EBITDA	5.93x	5.00x	5.04x	6.09x	5.07x	5.12x	8.31x	5.86x	5.60x	7.20x
Interest Coverage	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x	-
Total Equity+	996.08M	1.04B	1.03B	1.9B	1.65B	1.36B	1.39B	1.57B	2B	2.04B
Equity Growth %	4%	4.59%	-1.19%	84.91%	-13.26%	-17.33%	1.88%	13.19%	26.88%	1.93%
Book Value per Share	7.78	8.07	7.90	14.61	12.72	10.48	11.16	12.79	16.03	16.41
Total Shareholders' Equity	905.9M	932.6M	916.24M	770.97M	1.06B	1.11B	1.12B	1.29B	1.68B	1.71B
Common Stock	132K	134K	135K	134K	135K	134K	127K	128K	129K	124K
Retained Earnings	371.69M	359.74M	320.35M	279.8M	553.24M	593.25M	581.01M	751.86M	770.15M	837.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-512.75M	-630.66M	-764.58M	0	-2.03M	12.28M	88.6M	42.91M	0	-6.4M
Minority Interest	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M	18.81M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	346.6M	238.13M	494.19M	445.18M	1.03B	401.23M	284.82M	582.06M	517.86M	346.47M
Operating CF Margin %	8.09%	5.36%	9.73%	8.16%	18.59%	6.47%	4.5%	8.73%	9.98%	6.35%
Operating CF Growth %	66.3%	-31.3%	107.53%	-9.92%	130.93%	-60.97%	-29.01%	104.36%	-11.03%	-33.1%
Net Income	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	296.7M	146.22M
Depreciation & Amortization	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M	140.3M
Stock-Based Compensation	17.41M	19.28M	23.33M	26.45M	27.25M	30.94M	37.76M	43.81M	100.67M	16.7M
Deferred Taxes	-12.59M	-72.32M	7.22M	-7.43M	-14.71M	5.05M	7.52M	-16.12M	-32.43M	30.65M
Other Non-Cash Items	52.98M	85.75M	656K	25.65M	-13.82M	-7.38M	-4.76M	-13.6M	4.17M	12.59M
Working Capital Changes	18.22M	-175.24M	84.4M	-13.09M	479.1M	-329.98M	-159.54M	59.5M	-55.14M	0
Change in Receivables	-39.32M	-197.19M	54.58M	-57.99M	-116.6M	23.1M	-52.18M	1.16M	-95.84M	-45.19M
Change in Inventory	17.45M	1.6M	0	0	167.65M	-82.77M	0	0	0	0
Change in Payables	30.8M	21.24M	26.12M	5.74M	27.32M	53.39M	-48.04M	-6.41M	-16.79M	-854K
Cash from Investing+	-554.32M	-192.97M	-697.14M	-316.73M	-115.35M	-256.59M	-226.34M	-268.48M	-231.01M	-216.49M
Capital Expenditures	-161.63M	-233.24M	-167.28M	-157.13M	-146.44M	-180.54M	-190.37M	-229.2M	-222.18M	36.27M
CapEx % of Revenue	3.77%	5.25%	3.29%	2.88%	2.65%	2.91%	3.01%	3.44%	4.28%	0.67%
Acquisitions	-473.15M	-40.07M	-536.62M	-159.79M	-52.23M	-102.88M	-44.31M	-39.44M	-13.1M	-9.2M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	80.46M	80.35M	6.76M	192K	83.32M	26.82M	8.34M	163K	4.26M	-243.56M
Cash from Financing+	292.31M	-21.65M	255.57M	32.25M	-671.54M	-647.38M	-34.89M	-327.48M	-311.17M	-163.15M
Debt Issued (Net)	294.38M	-18.27M	570.92M	73.46M	-48.12M	195.7M	264.68M	-203.95M	-493.46M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	1000K	0
Dividends Paid	0	0	0	0	0	-50.6M	-64.59M	-63.9M	-64.62M	-31.43M
Share Repurchases	-2.93M	-4.75M	-6.84M	-38.53M	-16.03M	-79.48M	-195.53M	-12.76M	-37.91M	-100.08M
Other Financing	864K	1.38M	-308.51M	-2.68M	-607.39M	-713.01M	-39.45M	-46.86M	-226.38M	-131.72M
Net Change in Cash	84.59M	23.52M	52.63M	160.7M	241.18M	-502.75M	23.6M	-13.9M	-24.31M	-33.17M
Free Cash Flow+	184.97M	4.89M	326.91M	288.06M	881.63M	220.69M	94.45M	352.86M	539.65M	382.74M
FCF Margin %	4.32%	0.11%	6.43%	5.28%	15.94%	3.56%	1.49%	5.29%	10.4%	7.02%
FCF Growth %	617.69%	-97.36%	6588.07%	-11.89%	206.06%	-74.97%	-57.2%	273.58%	52.94%	-29.08%
FCF per Share	1.45	0.04	2.51	2.21	6.79	1.69	0.76	2.87	4.33	3.09
FCF Conversion (FCF/Net Income)	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x	2.37x
Interest Paid	142.64M	149.16M	193.41M	182.99M	155.24M	132.2M	183.45M	272.26M	256.23M	0
Taxes Paid	70.76M	64.99M	48.15M	70.59M	108.89M	181.18M	32.29M	88.51M	133.19M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	11.81%	17.39%	13.31%	10.12%	14.57%	26.67%	11.54%	16.43%	11.99%	7.25%
Return on Invested Capital (ROIC)	6.4%	7.36%	8.06%	6.93%	7.31%	9.21%	4.84%	6.66%	3.77%	0.03%
Gross Margin	14.49%	15.97%	14.57%	14.91%	14.85%	14.82%	11.58%	13.99%	12.22%	11.54%
Net Margin	2.69%	3.99%	2.71%	2.72%	4.68%	6.48%	2.51%	3.65%	4.13%	2.68%
Debt / Equity	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x	0.51x
Interest Coverage	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x	-
FCF Conversion	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x	2.37x
Revenue Growth	14.52%	3.68%	14.35%	7.33%	1.43%	12.16%	2.08%	5.22%	-22.16%	5.12%

Select Medical Holdings Corporation (SEM) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SEM vs Peers

vs ENSG

vs EHC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Select Medical Holdings Corporation (SEM) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SEM vs Peers

vs ENSG

vs EHC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios